InCarda Therapeutics Announces Enrollment of First Patient in Pivotal Phase 3 RESTORE-1 Trial of InRhythm™ for the Treatment of Paroxysmal Atrial Fibrillation
26 juil. 2022 07h00 HE
|
InCarda Therapeutics, Inc.
Single Pivotal Phase 3 Trial to Support Filing of New Drug Application Positive Phase 2 Efficacy and Safety Data for InRhythm Recently Highlighted as “Editor’s Pick” in Circulation: Arrhythmia...
Catheter Market Size is projected to reach USD 88 Billion by 2030, growing at a CAGR of 6.8%: Straits Research
27 juin 2022 13h00 HE
|
Straits Research
New York, United States, June 27, 2022 (GLOBE NEWSWIRE) -- Medical catheters are devices that can be injected into a body cavity, vessel, or duct to give fluids, medicines, or gases or drain fluids...
The Global Digital Biomarkers Market is anticipated to reach a substantial landmark of 23.31 Billion with a CAGR of 35.71%.
13 juin 2022 08h28 HE
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 13, 2022 (GLOBE NEWSWIRE) -- Digital biomarkers are regarded as physiological, quantifiable, and behavioural data that are collected & measured with the help of...
Global Catheters Market Is Expected to Reach $49.5 Billion by 2031: Says AMR
09 juin 2022 04h28 HE
|
Allied Market Research
Portland, OR, June 09, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Catheters Market was estimated at $22.7 billion in 2021 and is expected to hit...
Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design
01 juin 2022 09h00 HE
|
Recardio Inc.
SAN FRANCISCO, June 01, 2022 (GLOBE NEWSWIRE) -- Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin along with data suggesting potential positive...
Recardio's Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid
23 mai 2022 14h00 HE
|
Recardio Inc.
SAN FRANCISCO, May 23, 2022 (GLOBE NEWSWIRE) -- Entitled "Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptinin Combination with Filgrastim in Early...
Development: Global Medical Device Manufacturing Outsourcing Market Expected to Surpass $104.3 Million, Rising at 10.3% CAGR from 2019 to 2026 [215-Pages] | Reveals by Research Dive
11 mai 2022 09h06 HE
|
Research Dive
New York, USA, May 11, 2022 (GLOBE NEWSWIRE) -- A new report on the global medical device manufacturing outsourcing market has been added by Research Dive to its repository. According to the report,...
North America Fitness Equipment Market revenue to hit $6bn by 2026, says Graphical Research
04 mai 2022 07h00 HE
|
Graphical Research
Pune, India, May 04, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the North America fitness equipment market is forecast to register its name in the...
Healios AG Announces Addition of Anna Walz to Board of Directors
12 avr. 2022 14h00 HE
|
Healios AG
BASEL, Switzerland, April 12, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, announced that Anna Walz has been appointed...
Inventiva annonce la présentation d’un abstract scientifique lors de la prochaine International Conference on Fatty Liver
07 avr. 2022 16h00 HE
|
INVENTIVA
Daix (France), Long Island City (New York, Etats-Unis), le 7 avril 2022 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites...